ArticleJournal of cellular and molecular medicine2026
AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway.
Yuli Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.